Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTs for Malaria in African Pregnant Women
NCT00852423Phase 3Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Jun 2010
- Primary completion
- Oct 2013
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine, artesunate + mefloquine, artesunate + amodiaquine, artemether + lumefantrine in malaria, sponsored by Institute of Tropical Medicine Antwerp. Started Jun 2010; status: completed.
02
Drugs
dihydroartemisinin + piperaquineartesunate + mefloquineartesunate + amodiaquineartemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00852423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852423.